Tirzepatide is the first dual agonist which has been approved for chronic weight management, but numerous other dual and/or triple agonists (cagrisema, retatrutide, mazdutide and survodutide) are also in phase 3 trials as potential treatments for obesity and its metabolic complications
The result is typically slower weight loss but the same total weight loss over a longer period, with potentially less metabolic shock and less hair follicle disruption
Biohacking with Peptides: A Miami Executives Performance Guide A Miami executives guide to biohacking with peptides: matching performance goals to peptide categories, why medical supervision and labs matter, and how to start safely at Perfect B in Doral
Separate Use From Vitamin C Ascorbic acid can destabilize copper peptides
What is it used for
Microarray studies have identified over 4,000 human genes whose expression is modulated by GHK-Cu, spanning tissue remodeling, antioxidant defense, and growth factor signaling categories
